CTOs on the Move

Kolltan

www.kolltan.com

 
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.kolltan.com
  • 300 George St Ste 530
    New Haven, CT USA 06511
  • Phone: 203.773.3000

Executives

Name Title Contact Details

Similar Companies

Wilcox Health System

Wilcox Health System is a Lihue, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ageia Health Services

Ageia Health Services is a Bend, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Thermotex Therapy Systems

Thermotex Therapy Systems Ltd. is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dental Masters Laboratory

Dental Masters Laboratory is a Santa Rosa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TAKE Solutions

TAKE is an industry leader in providing the following services to Pharmaceutical companies such as: CDISC Services, where we offer the most effective data standardization solutions and consulting services. The OneClinical team under the leadership of a